University of Texas/MD Anderson CRC

Houston, Texas 77030-4009

0 studies enrolling now · 14 studies all time

What they study most

Allogeneic Hematopoietic Stem Cell Transplantation, Anemia, Aplastic, Anemia, Sickle Cell, Chronic GVHD, Follicular Lymphoma, Graft vs Host Disease, HIV, Immune System Disorders, Infection, Leukemia, Lymphoma, MDS

Studies at this site

• Bone Marrow Transplantation vs Standard of Care in Patients With Severe Sickle Cell Disease (BMT CTN 1503) — Completed
• Allo vs Hypomethylating/Best Supportive Care in MDS (BMTCTN1102) — Completed
• Autologous or Donor Stem Cell Transplantation in Treating Patients With Recurrent Non-Hodgkin's Lymphoma (BMT CTN 0202) — Stopped early
• Peripheral Blood Stem Cell Transplant vs Bone Marrow Transplant in Individuals With Hematologic Cancers (BMT CTN 0201) — Completed
• Comparison of Fluconazole vs Voriconazole to Treat Fungal Infections for Blood and Marrow Transplants (BMT CTN 0101) — Completed
• Allogeneic Hematopoietic Stem Cell Transplantation With Ixazomib for High Risk Multiple Myeloma (BMT CTN 1302) — Completed
• Prospective Cohort for the Evaluation of Biomarkers Following HCT (BMT CTN 1202) — Completed
• Allogeneic Transplant in HIV Patients (BMT CTN 0903) — Completed
• Stem Cell Transplant With Lenalidomide Maintenance in Patients With Multiple Myeloma (BMT CTN 0702) — Completed
• Treatment for Acute Graft-Versus-Host Disease (BMT CTN 0302) — Completed
• Fludarabine-based Conditioning for Severe Aplastic Anemia (BMT CTN 0301) — Completed
• STRIDE Biorepository — Status unconfirmed
• Continued, Long-Term Follow-Up and Lenalidomide Maintenance Therapy for Patients on BMT CTN 0702 Protocol (BMT CTN 07LT) — Completed
• Chronic Graft-versus-Host Disease Treatment (BMT CTN 0801) — Completed